China Traditional Chinese Medicine Holdings Co. Limited (HKG:0570)

HKG:0570 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3,593	3,942	3,867	3,017	3,065	2,895
Short-Term Investments	1,027	1,189	1,475	673.3	393.37	939.57
Cash & Short-Term Investments	4,619	5,131	5,342	3,691	3,458	3,834
Cash Growth	-12.35%	-3.95%	44.75%	6.71%	-9.80%	-19.66%
Accounts Receivable	7,618	8,379	8,169	9,171	7,620	8,343
Other Receivables	133.72	174.7	168.06	178.63	207.49	138.08
Receivables	7,752	8,553	8,337	9,350	7,827	8,481
Inventory	3,749	3,711	4,783	5,959	6,040	5,154
Prepaid Expenses	-	-	-	133.64	150.25	-
Other Current Assets	212.25	312.74	377.07	666.53	490.95	734.12
Total Current Assets	16,332	17,708	18,840	19,800	17,967	18,203
Property, Plant & Equipment	6,897	7,188	7,714	7,960	7,924	7,866
Long-Term Investments	10.67	10.72	10.92	11.85	15.35	18.01
Goodwill	1,886	2,531	3,026	3,458	3,456	3,492
Other Intangible Assets	4,305	4,492	5,106	5,486	5,875	6,258
Long-Term Deferred Tax Assets	266.82	248.81	219.98	219.48	202.07	187.47
Other Long-Term Assets	171.49	169.17	147.07	133.32	197.67	365
Total Assets	29,869	32,347	35,064	37,068	35,637	36,389

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2,014	2,207	2,237	2,743	1,889	2,093
Accrued Expenses	1,191	1,633	1,622	1,591	1,518	2,672
Current Portion of Long-Term Debt	849.83	2,215	2,101	2,951	4,497	2,156
Current Portion of Leases	20.75	18.65	22.61	18.59	16.76	15
Current Income Taxes Payable	15.56	36.56	53.45	103.05	66.29	153.57
Current Unearned Revenue	187.3	136.19	185.19	210.51	290.68	204.08
Other Current Liabilities	1,638	1,487	1,579	1,716	1,825	1,471
Total Current Liabilities	5,916	7,734	7,800	9,333	10,103	8,765
Long-Term Debt	424.14	207.75	1,817	2,111	466.06	2,810
Long-Term Leases	45.96	52.47	75.03	79.87	62.87	82.5
Long-Term Unearned Revenue	379.1	385.8	396.3	421.29	437.84	390.7
Long-Term Deferred Tax Liabilities	908.8	939.86	1,042	1,187	1,619	1,680
Total Liabilities	7,674	9,319	11,131	13,132	12,689	13,728

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	11,982	11,982	11,982	11,982	11,982	11,982
Retained Earnings	-	8,733	9,473	9,421	8,415	7,965
Comprehensive Income & Other	7,712	-245.73	-251.23	-243.07	-228.9	-229.02
Total Common Equity	19,695	20,470	21,204	21,160	20,168	19,719
Minority Interest	2,500	2,558	2,729	2,776	2,780	2,942
Shareholders' Equity	22,195	23,028	23,933	23,937	22,948	22,661
Total Liabilities & Equity	29,869	32,347	35,064	37,068	35,637	36,389

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,341	2,494	4,016	5,160	5,043	5,064
Net Cash (Debt)	3,278	2,638	1,327	-1,470	-1,584	-1,229
Net Cash Growth	96.02%	98.81%	-	-	-	-
Net Cash Per Share	0.65	0.52	0.26	-0.29	-0.31	-0.24
Filing Date Shares Outstanding	5,036	5,036	5,036	5,036	5,036	5,036
Total Common Shares Outstanding	5,036	5,036	5,036	5,036	5,036	5,036
Working Capital	10,416	9,975	11,039	10,467	7,864	9,439
Book Value Per Share	3.91	4.06	4.21	4.20	4.00	3.92
Tangible Book Value	13,504	13,447	13,072	12,216	10,837	9,969
Tangible Book Value Per Share	2.68	2.67	2.60	2.43	2.15	1.98
Machinery	-	3,838	3,744	3,559	3,288	2,953
Construction In Progress	-	221.32	490.11	773.48	544.81	617.66

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 18, 2026

Data Sources Report a data error